The Canadian Nosocomial Infection Surveillance Program (CNISP) is a sentinel hospital network that includes 106 acute care hospitals in 10 provinces and 1 territory. Established in 1995, the program is a collaboration between:
This network conducts surveillance of healthcare-associated infections on:
In addition, periodic point prevalence surveys are conducted on healthcare-associated infections including antimicrobial resistant organisms and antimicrobial usage. These surveys measure how common a particular characteristic, such as infection, illness or risk factors, during a particular point in time.
These data are used to help inform programs and policies related to:
For more information on
Visit our interactive data trends page for surveillance trends and recent publications
Canada’s Chief Public Health Officer is the federal government’s lead public health professional. The CPHO advises the Health Minister and the President of the Public Health Agency of Canada (PHAC). The CPHO also provides guidance for the work of PHAC and plays a leadership role in helping Canada to prepare for and respond to public health emergencies, working with provincial, territorial and international partners. The CPHO works to ensure that all people in Canada have an equal opportunity to be healthy and well.
Contact information
Email: CPHOCorrespondence@phac-aspc.gc.ca
Canadian Chief Public Health Officer
Position Statement
Resources
The internet can be a valuable source of information; it can also be difficult sometimes to tell what information is backed up by good science. Here are some reliable sites that can help answer your questions:
Federal Framework
Surveillance
FLYER
A flyer was developed to guide healthcare providers in discussing measles with the public and patients. The flyer covers three key points: measles is present in Canada, it can be stopped, and protection is safe.
National Advisory Committee on Immunization (NACI): Statements and publications
NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable diseases for whom vaccination should be targeted. NACI knowledge syntheses, analyses and recommendations on vaccine use in Canada are published in literature reviews, statements and updates.
Email updates are available through our mailing list. To subscribe to receive instant alerts when chapter updates and new NACI products are posted.
